Global Narcolepsy Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Report Id

45869

Publisher Name

Global Info Research

Published Date

2/18/2019

No of Pages

102

Market Scenario

Narcolepsy is a long-term neurological disorder that involves a decreased ability to regulate sleep-wake cycles. Symptoms include periods of excessive daytime sleepiness that usually last from seconds to minutes and may occur at any time. About 70% of people also experience episodes of sudden loss of muscle strength, known as cataplexy. These spells can be brought on by strong emotions. Less commonly, there may be inability to move or vivid hallucinations while falling asleep or waking up. People with narcolepsy tend to sleep about the same number of hours per day as people without, but the quality of sleep tends to be worse. Scope of the Report: The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years. The classification of narcolepsy drug includes antioxidants type, stimulants type and other types, and the proportion of antioxidants type in 2016 is about 78% in the world. Narcolepsy drug is widely used for daytime extreme sleepiness, cataplexia and other field. The most proportion of narcolepsy drug is used for cataplexia, and the consumption proportion in 2016 is about 57%. The worldwide market for Narcolepsy Drug is expected to grow at a CAGR of roughly 10.4% over the next five years, will reach 3310 million US$ in 2024, from 1830 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Narcolepsy Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Jazz Pharmaceuticals  Teva Pharmaceutical Novartis Mylan Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Antioxidants Type Stimulants Type Other Market Segment by Applications, can be divided into Daytime Extreme Sleepiness Cataplexia Others The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Narcolepsy Drug product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Narcolepsy Drug, with price, sales, revenue and global market share of Narcolepsy Drug in 2017 and 2018. Chapter 3, the Narcolepsy Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Narcolepsy Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Narcolepsy Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Narcolepsy Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Table of Contents 1 Market Overview 1.1 Narcolepsy Drug Introduction 1.2 Market Analysis by Type 1.2.1 Antioxidants Type 1.2.2 Stimulants Type 1.2.3 Other 1.3 Market Analysis by Applications 1.3.1 Daytime Extreme Sleepiness 1.3.2 Cataplexia 1.3.3 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2014-2024) 1.4.1.2 Canada Market States and Outlook (2014-2024) 1.4.1.3 Mexico Market States and Outlook (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2014-2024) 1.4.2.2 France Market States and Outlook (2014-2024) 1.4.2.3 UK Market States and Outlook (2014-2024) 1.4.2.4 Russia Market States and Outlook (2014-2024) 1.4.2.5 Italy Market States and Outlook (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2014-2024) 1.4.3.2 Japan Market States and Outlook (2014-2024) 1.4.3.3 Korea Market States and Outlook (2014-2024) 1.4.3.4 India Market States and Outlook (2014-2024) 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2014-2024) 1.4.4.2 Egypt Market States and Outlook (2014-2024) 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024) 1.4.4.4 South Africa Market States and Outlook (2014-2024) 1.4.4.5 Turkey Market States and Outlook (2014-2024) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Jazz Pharmaceuticals  2.1.1 Business Overview 2.1.2 Narcolepsy Drug Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Jazz Pharmaceuticals  Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.2 Teva Pharmaceutical 2.2.1 Business Overview 2.2.2 Narcolepsy Drug Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Teva Pharmaceutical Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.3 Novartis 2.3.1 Business Overview 2.3.2 Narcolepsy Drug Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Novartis Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 2.4 Mylan 2.4.1 Business Overview 2.4.2 Narcolepsy Drug Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Mylan Narcolepsy Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018) 3 Global Narcolepsy Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018) 3.1 Global Narcolepsy Drug Sales and Market Share by Manufacturer (2017-2018) 3.2 Global Narcolepsy Drug Revenue and Market Share by Manufacturer (2017-2018) 3.3 Market Concentration Rate 3.3.1 Top 3 Narcolepsy Drug Manufacturer Market Share in 2018 3.3.2 Top 6 Narcolepsy Drug Manufacturer Market Share in 2018 3.4 Market Competition Trend 4 Global Narcolepsy Drug Market Analysis by Regions 4.1 Global Narcolepsy Drug Sales, Revenue and Market Share by Regions 4.1.1 Global Narcolepsy Drug Sales and Market Share by Regions (2014-2019) 4.1.2 Global Narcolepsy Drug Revenue and Market Share by Regions (2014-2019) 4.2 North America Narcolepsy Drug Sales and Growth Rate (2014-2019) 4.3 Europe Narcolepsy Drug Sales and Growth Rate (2014-2019) 4.4 Asia-Pacific Narcolepsy Drug Sales and Growth Rate (2014-2019) 4.5 South America Narcolepsy Drug Sales and Growth Rate (2014-2019) 4.6 Middle East and Africa Narcolepsy Drug Sales and Growth Rate (2014-2019) 5 North America Narcolepsy Drug by Country 5.1 North America Narcolepsy Drug Sales, Revenue and Market Share by Country 5.1.1 North America Narcolepsy Drug Sales and Market Share by Country (2014-2019) 5.1.2 North America Narcolepsy Drug Revenue and Market Share by Country (2014-2019) 5.2 United States Narcolepsy Drug Sales and Growth Rate (2014-2019) 5.3 Canada Narcolepsy Drug Sales and Growth Rate (2014-2019) 5.4 Mexico Narcolepsy Drug Sales and Growth Rate (2014-2019) 6 Europe Narcolepsy Drug by Country 6.1 Europe Narcolepsy Drug Sales, Revenue and Market Share by Country 6.1.1 Europe Narcolepsy Drug Sales and Market Share by Country (2014-2019) 6.1.2 Europe Narcolepsy Drug Revenue and Market Share by Country (2014-2019) 6.2 Germany Narcolepsy Drug Sales and Growth Rate (2014-2019) 6.3 UK Narcolepsy Drug Sales and Growth Rate (2014-2019) 6.4 France Narcolepsy Drug Sales and Growth Rate (2014-2019) 6.5 Russia Narcolepsy Drug Sales and Growth Rate (2014-2019) 6.6 Italy Narcolepsy Drug Sales and Growth Rate (2014-2019) 7 Asia-Pacific Narcolepsy Drug by Country 7.1 Asia-Pacific Narcolepsy Drug Sales, Revenue and Market Share by Country 7.1.1 Asia-Pacific Narcolepsy Drug Sales and Market Share by Country (2014-2019) 7.1.2 Asia-Pacific Narcolepsy Drug Revenue and Market Share by Country (2014-2019) 7.2 China Narcolepsy Drug Sales and Growth Rate (2014-2019) 7.3 Japan Narcolepsy Drug Sales and Growth Rate (2014-2019) 7.4 Korea Narcolepsy Drug Sales and Growth Rate (2014-2019) 7.5 India Narcolepsy Drug Sales and Growth Rate (2014-2019) 7.6 Southeast Asia Narcolepsy Drug Sales and Growth Rate (2014-2019) 8 South America Narcolepsy Drug by Country 8.1 South America Narcolepsy Drug Sales, Revenue and Market Share by Country 8.1.1 South America Narcolepsy Drug Sales and Market Share by Country (2014-2019) 8.1.2 South America Narcolepsy Drug Revenue and Market Share by Country (2014-2019) 8.2 Brazil Narcolepsy Drug Sales and Growth Rate (2014-2019) 8.3 Argentina Narcolepsy Drug Sales and Growth Rate (2014-2019) 8.4 Colombia Narcolepsy Drug Sales and Growth Rate (2014-2019) 9 Middle East and Africa Narcolepsy Drug by Countries 9.1 Middle East and Africa Narcolepsy Drug Sales, Revenue and Market Share by Country 9.1.1 Middle East and Africa Narcolepsy Drug Sales and Market Share by Country (2014-2019) 9.1.2 Middle East and Africa Narcolepsy Drug Revenue and Market Share by Country (2014-2019) 9.2 Saudi Arabia Narcolepsy Drug Sales and Growth Rate (2014-2019) 9.3 Turkey Narcolepsy Drug Sales and Growth Rate (2014-2019) 9.4 Egypt Narcolepsy Drug Sales and Growth Rate (2014-2019) 9.5 Nigeria Narcolepsy Drug Sales and Growth Rate (2014-2019) 9.6 South Africa Narcolepsy Drug Sales and Growth Rate (2014-2019) 10 Global Narcolepsy Drug Market Segment by Type 10.1 Global Narcolepsy Drug Sales, Revenue and Market Share by Type (2014-2019) 10.1.1 Global Narcolepsy Drug Sales and Market Share by Type (2014-2019) 10.1.2 Global Narcolepsy Drug Revenue and Market Share by Type (2014-2019) 10.2 Antioxidants Type Sales Growth and Price 10.2.1 Global Antioxidants Type Sales Growth (2014-2019) 10.2.2 Global Antioxidants Type Price (2014-2019) 10.3 Stimulants Type Sales Growth and Price 10.3.1 Global Stimulants Type Sales Growth (2014-2019) 10.3.2 Global Stimulants Type Price (2014-2019) 10.4 Other Sales Growth and Price 10.4.1 Global Other Sales Growth (2014-2019) 10.4.2 Global Other Price (2014-2019) 11 Global Narcolepsy Drug Market Segment by Application 11.1 Global Narcolepsy Drug Sales Market Share by Application (2014-2019) 11.2 Daytime Extreme Sleepiness Sales Growth (2014-2019) 11.3 Cataplexia Sales Growth (2014-2019) 11.4 Others Sales Growth (2014-2019) 12 Narcolepsy Drug Market Forecast (2019-2024) 12.1 Global Narcolepsy Drug Sales, Revenue and Growth Rate (2019-2024) 12.2 Narcolepsy Drug Market Forecast by Regions (2019-2024) 12.2.1 North America Narcolepsy Drug Market Forecast (2019-2024) 12.2.2 Europe Narcolepsy Drug Market Forecast (2019-2024) 12.2.3 Asia-Pacific Narcolepsy Drug Market Forecast (2019-2024) 12.2.4 South America Narcolepsy Drug Market Forecast (2019-2024) 12.2.5 Middle East and Africa Narcolepsy Drug Market Forecast (2019-2024) 12.3 Narcolepsy Drug Market Forecast by Type (2019-2024) 12.3.1 Global Narcolepsy Drug Sales Forecast by Type (2019-2024) 12.3.2 Global Narcolepsy Drug Market Share Forecast by Type (2019-2024) 12.4 Narcolepsy Drug Market Forecast by Application (2019-2024) 12.4.1 Global Narcolepsy Drug Sales Forecast by Application (2019-2024) 12.4.2 Global Narcolepsy Drug Market Share Forecast by Application (2019-2024) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

Methodology

This research report involves complete picture of the market with the help of in-depth secondary and primary research. This research report studies several aspects of the market and analyze vital industry influencers. Extensive secondary research has been conducted using paid as well as open access data sources in order to gather information on the market and parent market. These key findings are then analyzed and validated with the help of in-house data models and primary discussions with key industry participants and experts across the value chain

research-methodology

Research Tools and Models

  • Top-Down Approach and Bottom-Up Approach
  • QFD Modeling for Market Size and Share Calculation
  • Regression, Variable and Impact Analysis
  • Penetration Modeling

Qualitative Research

  • It comprises briefing about market dynamics and business opportunities and strategies.
  • Finally, all the research findings are validated through interviews with in-house industry experts, freelance consultants and key opinion leaders etc.

Quantitative Research

It involves various mathematical tools, models, projection, and sampling techniques. It involves following steps:

  • Identification of market variables and market size derivation
  • Assessment of future prospects, opportunities and market penetration rates by analyzing product commercialization, regional trends etc.
  • Evaluation historical market trends and derivation of present and future year-on-year growth trends

Fill below details to get free sample !!

Contact Us
Call Now